Recent Advances in the Neoadjuvant Treatment of Breast Cancer.

J Breast Cancer · 2017 · PMC5500395 · PMID 28690648

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

difference was apparentno p-value reported

The difference was apparent in HR+ subgroup (37.9% vs. 44.8%), but it was more pronounced between HR− subgroups (53.8% vs. 72.4%) [ 54 ].

also in 830 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.